Fine mapping the MHC region identified four independent variants modifying susceptibility to chronic hepatitis B in Han Chinese.

Several genome-wide association studies (GWAS) have demonstrated the association between genetic variants in the major histocompatibility complex (MHC) region and chronic hepatitis B (CHB) virus infection, but it is still unknown about the disease-causing loci and potential mechanisms owing to the complicated linkage disequilibrium for this region. To systematically characterize the MHC variations in relation to the CHB infection, we fine mapped the MHC region on our existing GWAS data with SNP2HLA taken the Pan-Asian panel as reference and finally identified four independent associations. The HLA-DPβ1 amino acid positions 84-87, which drove the effect of reported single nucleotide polymorphisms rs9277535 and rs3077, showed the most significant association (OR = 0.65, P = 2.03 × 10(-8)). The Leu-15 of HLA-C, conferring the effect of rs3130542, increased the risk of CHB infection independently (OR = 1.61, P = 3.42 × 10(-7)). The HLA-DRβ1*13, in perfect LD with glutamic at site 71, and rs400488, an expression quantitative trait locus for HLA-J, were newly identified to be associated with CHB infection independently (OR = 1.84, P = 3.84 × 10(-9); OR = 0.28, P = 6.27 × 10(-7), respectively). HLA-DPβ1 positions 84-87 and HLA-DRβ1 position 71 implicated the P1 and P4 in the antigen-binding groove, whereas HLA-C position 15 affected the signal peptide. These four independent loci together can explain ∼ 6% of the phenotypic variance for CHB infection, accounting for 72.94% of that explained by known genetic variations. We fine mapped the MHC region and identified four loci that independently drove the chronic HBV infection. The results provided a deeper understanding of the GWAS signals and identified additional susceptibility loci which were missed in previous association studies.

[1]  Hongbing Shen,et al.  Telomere length, genetic variants and gastric cancer risk in a Chinese population. , 2015, Carcinogenesis.

[2]  James T. Elder,et al.  Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases , 2015, Nature Genetics.

[3]  Buhm Han,et al.  Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk , 2015, Nature Genetics.

[4]  M. Kanai,et al.  Construction of a population-specific HLA imputation reference panel and its application to Graves' disease risk in Japanese , 2015, Nature Genetics.

[5]  Cisca Wijmenga,et al.  Fine-mapping in the MHC region accounts for 18% additional genetic risk for celiac disease , 2015, Nature Genetics.

[6]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[7]  Jian Gu,et al.  Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region , 2022 .

[8]  Guohong Deng,et al.  Effect of HLA‐DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e‐antigen seropositive chronic hepatitis B patients , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[9]  Y. Okada,et al.  Predicting HLA alleles from high-resolution SNP data in three Southeast Asian populations. , 2014, Human molecular genetics.

[10]  Y. Okada,et al.  Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. , 2014, Human molecular genetics.

[11]  K. To,et al.  HLA‐DP and γ‐interferon receptor‐2 gene variants and their association with viral hepatitis activity in chronic hepatitis B infection , 2014, Journal of gastroenterology and hepatology.

[12]  Hongbing Shen,et al.  New loci associated with chronic hepatitis B virus infection in Han Chinese , 2013, Nature Genetics.

[13]  H. Shin,et al.  A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. , 2013, Human molecular genetics.

[14]  Buhm Han,et al.  Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[15]  Christoph Zehe,et al.  Optimized signal peptides for the development of high expressing CHO cell lines , 2013, Biotechnology and bioengineering.

[16]  J. Vincent,et al.  A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder , 2012, Molecular Psychiatry.

[17]  Hongbing Shen,et al.  Genetic variants in human leukocyte antigen/DP‐DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development , 2012, Hepatology.

[18]  P. Visscher,et al.  A Better Coefficient of Determination for Genetic Profile Analysis , 2012, Genetic epidemiology.

[19]  Gretchen A. Stevens,et al.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. , 2012, Vaccine.

[20]  Y. Kamatani,et al.  A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. , 2011, Human molecular genetics.

[21]  Y. Kamatani,et al.  A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians , 2009, Nature Genetics.

[22]  C. Chu,et al.  Hepatitis B virus infection , 2009, The Lancet.

[23]  A. Velayati,et al.  Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection , 2008, Journal of gastroenterology and hepatology.

[24]  P. Tangkijvanich,et al.  Association of HLA‐DRB1*13 and TNF‐α gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population , 2007, Journal of viral hepatitis.

[25]  Yingli He,et al.  Host susceptibility to persistent hepatitis B virus infection. , 2006, World journal of gastroenterology.

[26]  M. Pender,et al.  The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRβ1 chain is associated with the clinical course of multiple sclerosis , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  M. Amicosante,et al.  Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. , 2003, International immunology.

[28]  Jia-huai Wang,et al.  Structural basis of T cell recognition of peptides bound to MHC molecules. , 2002, Molecular immunology.

[29]  J. Gorski,et al.  Polymorphism at beta 85 and not beta 86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism. , 1997, International immunology.

[30]  T R Bender,et al.  Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. , 1985, The Journal of infectious diseases.